member

Previous page Rita RAISMAN-VOZARI Porteur de projet, PhD, DR2 emeritus, CNRS Team “Experimental therapeutics of Parkinson’s disease — ETPD”

Biography

Present position
CNRS Research Director, Emeritus, Institut du Cerveau, Paris
Education
-1982 PhD in Neuropharmacology, Université Pierre et Marie Curie, France
-1972 Graduation in Biochemistry, University of Tucuman, Argentina
Professional experience
-2011-present Research Director Emeritus, Institut du Cerveau (IC)
-2001-2011 Research Director, CNRS, Inserm U679 (Dir. Dr Hirsch), Paris, France
-1983-2000 Research Associate, CNRS, Inserm U289 (Dir. Pr Agid), Paris, France
-1979 Research Associate, Synthelabo Paris, France
-1977 Research Fellowship, Fondation pour la Recherche Médicale, Paris, France
-1976 Research Fellowship, Inserm, Paris, France
-1975 Research Fellowship, CONICET, Argentina
-1974 Teaching Assistant in Physiology, School of Medicine, Argentina

Research work

Analysis of neuronal death of dopaminergic neurons in Parkinson's disease. Neuroprotective role of antibiotics in Parkinson's and Alzheimer's disease. Research into tetracycline derivatives without antibiotic activity for the treatment of neurodegenerative diseases. Inhibition of alphasynuclein and tau aggregation by tetracyclines.

Publications

- Dominguez-Meijide A, Parrales V, Vasili E, González-Lizárraga F, König A, Lázaro DF, Lannuzel A, Haik S, Del Bel E, Chehín R, Raisman-Vozari R, Michel PP, Bizat N, Outeiro TF. Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo Neurobiol Dis. 2021 Apr;151:105256. https://doi.org/10.1016/j.nbd.2021.105256. - Mauricio Dos-Santos-Pereira, Franscisco S Guimarães , Elaine Del-Bel, Rita Raisman-Vozari , Patrick P Michel. Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption Glia 2020 Mar;68(3):561-573. https://doi.org/10.1002/glia.23738 - Santa-Cecília FV, Leite CA, Del-Bel E, Raisman-Vozari R. Neurotox Res. The Neuroprotective Effect of Doxycycline on Neurodegenerative Diseases.2019 May;35(4):981-986. https://doi.org/10.1007/s12640-019-00015-z. - Acuña L, Hamadat S, Corbalán NS, González-Lizárraga F, Dos-Santos-Pereira M, Rocca J, Díaz JS, Del-Bel E, Papy-García D, Chehín RN, Michel PP, Raisman-Vozari R. Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates. Cells. 2019 Jul 25;8(8). pii: E776. https://doi.org/10.3390/cells8080776 - Socias SB, González-Lizárraga F, Avila CL, Vera C, Acuña L, Sepulveda-Diaz JE, Del-Bel E, Raisman-Vozari R, Chehin RN. Exploiting the therapeutic potential of ready-to-use drugs: Repurposing antibiotics against amyloid aggregation in neurodegenerative diseases. Prog Neurobiol. 2018 Mar;162:17-36. https://doi.org/10.1016/j.pneurobio.2017.12.002